Matthew Coons

Title: The Innovative Contributions of Matthew Coons

Introduction

Matthew Coons is an accomplished inventor based in Dearborn, Missouri. He has made significant strides in the field of immunology through his innovative methods and compositions. His work focuses on enhancing the efficacy of immunogenic compositions, which are crucial for vaccine development and disease prevention.

Latest Patents

Matthew Coons holds a patent for a "Method of producing an immunogenic composition." This invention specifically relates to a method that exhibits reduced virucidal activity while producing an immunogenic composition. The method involves several key steps: first, providing a mixture containing a first liquid and a recombinant protein; second, concentrating the recombinant protein by removing a portion of the first liquid; and third, processing the resulting solution through continuous diafiltration. This innovative approach has the potential to improve vaccine formulations and their effectiveness.

Career Highlights

Throughout his career, Matthew Coons has demonstrated a commitment to advancing scientific knowledge and practical applications in immunology. His patent reflects his dedication to developing methods that can lead to better health outcomes. With a focus on immunogenic compositions, he has positioned himself as a valuable contributor to the field.

Collaborations

Matthew has collaborated with notable colleagues, including Francois-Xavier Orveillon and Katharina Hedwig Toepfer. These partnerships have likely enriched his research and contributed to the success of his innovative projects.

Conclusion

In summary, Matthew Coons is a notable inventor whose work in producing immunogenic compositions showcases his innovative spirit and dedication to improving public health. His contributions are significant in the ongoing efforts to enhance vaccine efficacy and disease prevention.